Amneal Launches Budesonide Capsules

BRIDGEWATER, N.J., Jan. 18, 2018 /PRNewswire/ -- Amneal Pharmaceuticals has launched budesonide capsules, 3 mg, an AB-rated equivalent to Entocort® EC. Annual U.S. sales of budesonide and its generic equivalents were $187 million, according to November 2017 IQVIA™ market data. Budes...